Company Overview

Development Stage

About the Company

[Summary] 四环医药旗下创新药研发平台

轩竹医药是一家新分子实体创新药物研发商,主要进行新分子实体药物的研究和开发,研究的领域主要包括抗感染领域、抗心血管代谢疾病领域、抗肿瘤领域等比较前沿的新药研发领域。公司在创新药领域的投资已超20亿,目前已经形成完整的新药研究开发体系,具有从新药结构设计、评价、确立候选化合物,到临床研究,再到新药上市申请的专业平台。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

轩竹生物 Financing History (5 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

轩竹生物 How Fast Is Hiring Growing?

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 50%
  • 2024: Down 80%
  • 2023: Up 25%
  • 2022: Down 11%
轩竹生物 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 轩竹生物科技股份有限公司 growing? 轩竹生物2026: 21 openings (up 600%), 2025: 3 openings (up 50%), 2024: 2 openings (down 80%), 2023: 10 openings (up 25%), 2022: 8 openings (down 11%), 2021: 9 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

轩竹生物 Master's Degree Job Demand Analysis

(More)
+500%
Growth Rate
2026 vs 2025
轩竹生物 Master's Hiring by Year: 2026 — 5 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 轩竹生物科技股份有限公司 growing? 轩竹生物Master's recruitment over the years: 2026: 6 openings (up 600%), 2025: 1 openings (up 50%), 2022: 2 openings (down 11%).

轩竹生物 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
轩竹生物 Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 轩竹生物科技股份有限公司 growing? 轩竹生物Doctorate recruitment over the years: 2026: 1 openings (up 600%), 2023: 1 openings (up 25%).

轩竹生物 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 轩竹生物科技股份有限公司? Based on an analysis of 轩竹生物's job postings over the past year, "医疗卫生/美容保健类" demand: 58.8%, "生物/制药/化工/环保类": 17.6%, "其他(研发和技术类)": 11.8%, "科研类": 11.8%. For reference only.

轩竹生物 — What Are the Salaries Like? (17 records)

Manage
轩竹生物 Salary Overview
salary range: 8K - 50K, 88.2% of roles pay ¥10-30K
Note: salary statistics are based on 17 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 轩竹生物科技股份有限公司?轩竹生物88.2% of positions earn 10-30K, Undergraduate salary: ¥。Shijiazhuang salary ranking top 20,销售类 average salary ¥17.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

轩竹生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

轩竹生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    68.2% of total 68.2%
  • 医疗卫生/美容保健类
    63.6% of total 63.6%
  • 生物/制药/化工/环保类
    22.7% of total 22.7%
  • 其他(研发和技术类)
    18.2% of total 18.2%

Education

  • 本科
    63.6% of total 63.6%
  • 硕士
    27.3% of total 27.3%
  • 大专
    4.5% of total 4.5%
  • 博士
    4.5% of total 4.5%

Experience

  • 3-5年
    40.9% of total 40.9%
  • 1-3年
    22.7% of total 22.7%
  • 5-10年
    22.7% of total 22.7%
  • 不限
    13.6% of total 13.6%
View Detailed Analysis

What does 轩竹生物科技股份有限公司 require? Who is 轩竹生物 hiring? 轩竹生物 recruitment: 销售类占比最多占68.2%,其次是医疗卫生/美容保健类占63.6%. What education can get in at 轩竹生物? 本科占比最多占63.6%,其次是硕士占27.3%. High education required at 轩竹生物? 硕士占27.3%,博士占4.5%. Work experience required at 轩竹生物? 3-5年占比最多占40.9%,其次是1-3年占22.7%. Where are the job locations at 轩竹生物? 北京占比最多占40.9%,其次是济南占9.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 51,794.779万(元)
Legal Representative: 徐艳君
Date Established:
Credit Code: 91460100MA5T63AY5W
Registered Address: 河北省石家庄市高新区太行大街769号京津冀协作创新示范园203C507

Partners & Suppliers

授权其在中国大陆地区商业化轩竹生物自主研发的1类新药吡罗西尼(XZP-3287) Source
合作客户 商业化合作
提供基因编辑小鼠模型及药物筛选服务 Source
供应商 模式动物
提供药物非临床安全性评价服务 Source
供应商 药物安全性评价
提供药物研发外包服务 Source
供应商 药物研发外包
提供药物发现及临床前CRO服务 Source
供应商 药物研发外包

People who follow 轩竹生物 also follow

轩竹生物 Competitors (Similar Companies)

数码印刷 商业印刷 生产 画册
新材料 丙烷 化工新材料 石油
“One of the world's top five and China's top three fiberglass manufactu”
“Let every Chinese family enjoy the care of professional home medical c”
“Main business: design, development, production, sales, and service of ”
影视 动漫 研发 传媒集团
“Specialized in servo control systems, airborne video systems, and comp”
制药/药业 医药 心血管药 醋氯芬酸
“A total solution service provider dedicated to improving the reliabili”
“A leader in the diabetes field”
药物研发 CRO 临床用药 科学服务
无菌医疗器械 医疗科技 治疗设备 生产
“Leading enterprise of the National Biological Industry Base”
制药/药业 原料药 化学原料药 中药提取
“Intelligent safety detection and monitoring equipment for rail transit”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates